Hypoxia-inducible factor for the treatment of anemia in chronic kidney disease

Hypoxia-inducible factor for the treatment of anemia in chronic kidney disease

Studies in the field of oxygen-dependent regulation of erythropoiesis provided new data on the pathogenesis of anemia associated with chronic kidney disease, which led to the development of therapeutic agents for treatment. A new class of agents for the treatment of anemia in chronic kidney disease...

Full description

Bibliographic Details
Main Author:	O.O. Melnyk
Format:	Article
Language:	English
Published:	Publishing House Zaslavsky 2018-10-01
Series:	Počki
Subjects:	anemia chronic kidney disease hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat vadadustat daprodustat molidustat review
Online Access:	http://kidneys.zaslavsky.com.ua/article/view/148522

Similar Items

Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
by: Joshua M. Kaplan, et al.
Published: (2018-01-01)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
by: Andrey A. Poloznikov, et al.
Published: (2021-01-01)

New expectations in the treatment of anemia in chronic kidney disease
by: Juan M. López-Gómez, et al.
Published: (2016-05-01)

Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis
by: Qiyan Zheng, et al.
Published: (2021-01-01)

Whether Prolyl Hydroxylase Blocker—Roxadustat—in the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?
by: Władysław Grzeszczak, et al.
Published: (2021-02-01)

Hypoxia Induced Factor in Chronic Kidney Disease: Friend or Foe?
by: Weiying Li, et al.
Published: (2018-01-01)

A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease: SYMPHONY HD Study
by: Tadao Akizawa, et al.
Published: (2021-07-01)

A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat
by: Zhipeng Yan, et al.
Published: (2020-08-01)

Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia
by: Xiaofan Hu, et al.
Published: (2020-12-01)

Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
by: Ishii T, et al.
Published: (2021-02-01)

Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
by: Jose Portolés, et al.
Published: (2021-03-01)

Safety and Efficacy of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis
by: Chao Liu, et al.
Published: (2021-08-01)

mRNA expression profile of selected oxygen sensing genes in the lung during recovery from chronic hypoxia
by: Alice Panariti, et al.
Published: (2013-01-01)

Hypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair
by: Shaoqun Shu, et al.
Published: (2019-02-01)

Editorial: The Development of New Classes of Hypoxia Mimetic Agents for Clinical Use
by: Ruoli Chen, et al.
Published: (2019-06-01)

Stabilization of Hypoxia-Inducible Factor Promotes Antimicrobial Activity of Human Macrophages Against Mycobacterium tuberculosis
by: Sebastian F. Zenk, et al.
Published: (2021-06-01)

Rank Order of Small Molecule Induced Hypoxiamimesis to Prevent Retinopathy of Prematurity
by: George Hoppe, et al.
Published: (2020-06-01)

Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat
by: Mei Tang, et al.
Published: (2021-07-01)

L-mimosine and hypoxia can increase angiogenin production in dental pulp-derived cells
by: Klara Janjić, et al.
Published: (2017-05-01)

Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
by: Sundary Sormendi, et al.
Published: (2018-01-01)

Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study
by: Yaling Zhang, et al.
Published: (2021-01-01)

Reactive Oxygen Species Formation in the Brain at Different Oxygen Levels: The Role of Hypoxia Inducible Factors
by: Ruoli Chen, et al.
Published: (2018-10-01)

Prolyl 3-hydroxylases and hypoxia-inducible factor 3:their roles in collagen synthesis and hypoxia response, respectively
by: Pasanen, A. (Annika)
Published: (2011)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
by: Maria Savyuk, et al.
Published: (2020-07-01)

Anemia in Chronic Kidney Disease : Role of Hypoxia Inducible Factor Stabilizer
by: Emilia, et al.
Published: (2021-02-01)

Suppression of collagen IV alpha‐2 subunit by prolyl hydroxylase domain inhibition via hypoxia‐inducible factor‐1 in chronic kidney disease
by: Mohammad Sanaei‐Ardekani, et al.
Published: (2021-10-01)

Local Stabilization of Hypoxia-Inducible Factor-1α Controls Intestinal Inflammation via Enhanced Gut Barrier Function and Immune Regulation
by: Young-In Kim, et al.
Published: (2021-01-01)

The role of hypoxia-inducible factor stabilizers in the treatment of anemia in patients with chronic kidney disease
by: Zhong H, et al.
Published: (2018-09-01)

Advances of Hypoxia and Lung Cancer
by: Xuebing LI, et al.
Published: (2013-04-01)

Prolyl Hydroxylase 3 Knockdown Accelerates <i>VHL</i>-Mutant Kidney Cancer Growth In Vivo
by: Niki M. Zacharias, et al.
Published: (2021-03-01)

New perspectives on the molecular basis of the interaction between oxygen homeostasis and iron metabolism
by: Recalcati S, et al.
Published: (2015-12-01)

Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α
by: Molly E. Ogle, et al.
Published: (2012-02-01)

Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition
by: Chintala Sreenivasulu, et al.
Published: (2012-07-01)

The Effects of Hypoxia and Inflammation on Synaptic Signaling in the CNS
by: Gatambwa Mukandala, et al.
Published: (2016-02-01)

A genetically encoded biosensor for visualising hypoxia responses in vivo
by: Tvisha Misra, et al.
Published: (2017-02-01)

Hypoxia — a Leading Factor of Chronic Kidney Disease Progression
by: O.Yu. Lysianska
Published: (2016-02-01)

Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
by: So Yeon Kim, et al.
Published: (2015-11-01)

Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells
by: Peter A.C. Wing, et al.
Published: (2021-04-01)

Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer
by: Luisa Iommarini, et al.
Published: (2017-11-01)

Prolyl hydroxylases:cloning and characterization of novel human and plant prolyl 4-hydroxylases, and three human prolyl 3-hydroxylases
by: Fonsén, P. (Päivi)
Published: (2007)